Literature DB >> 31864447

Dupuytren contracture as a sign of systemic disease.

Ivan Bogdanov1, Christopher Rowland Payne2.   

Abstract

Dupuytren contracture (DC) is predominantly an autosomal dominant disorder characterized by hypertrophy and contraction of the palmar fascia that results in tethered flexion of the affected digits. It has its highest prevalence in the North European population or in people of Viking descent, and its incidence is growing with age. DC shares a common inheritance mode, predisposing factors, comorbidities, pathophysiology, and evolution with Ledderhose disease, Garrod knuckle pads, and Peyronie disease. Nonmelanoma skin cancer also has a higher incidence in the population of North European phenotype and apparently a common genetic polymorphism. Psoriasis shares many risk factors and comorbidities with DC and has a higher prevalence in patients with DC. We suggest a close relationship among DC, some skin malignancies, and psoriasis. Regular monitoring for those skin diseases in all patients with DC is highly recommended.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31864447     DOI: 10.1016/j.clindermatol.2019.07.027

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  3 in total

Review 1.  Dupuytren's Disease: An Outcomes-Focused Update.

Authors:  Yasser H Almadani; Joshua Vorstenbosch; Johnny Ionut Efanov; Liqin Xu
Journal:  Semin Plast Surg       Date:  2021-07-06       Impact factor: 2.195

2.  Case Report: Cutaneous Squamous Cell Carcinoma Arising From the Ulcer of the Lesions of Dupuytren's Disease on the Palm.

Authors:  Qingmiao Sun; Bin Fu; Sheng Li; Hong Fang; Jianjun Qiao
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

3.  The Effect of Shock Wave Therapy on Improving the Symptoms and Function of Patients with Dupuytren's Contracture.

Authors:  Parisa Taheri; Najmeh Salek; Maryam Mousavi; Razieh Maghroori
Journal:  Adv Biomed Res       Date:  2022-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.